Clinical trial
Fluvastatin in the Therapy of Acute Coronary Syndrome
NCT00171275 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00171275 |
|---|---|
| Title | Fluvastatin in the Therapy of Acute Coronary Syndrome |
| Official title | Fluvastatin in the Therapy of Acute Coronary Syndrome |
| Lead sponsor | Novartis, Industry |
| Collaborators | Ministry of Health, Czech Republic |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease, Myocardial Infarction |
| Intervention type | Drug |
| Interventions | Fluvastatin |
| Enrollment | 1,000 |
| Start date | Nov 1, 2003 |
| Primary completion | Feb 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jul 16, 2010 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: